Colleen Delaney

Colleen Delaney

Company: Deverra Therapeutics

Job title: Founder and Chief Scientific Officer, EVP of Research and Development

Seminars:

Panel Discussion: What Criteria Make the Ideal Starting Material for Allogeneic Products? 3:40 pm

View the full event guide for more detailsRead more

day: Manufacturing Track Day One PM

Overcoming Hurdles in Allogeneic Cell Therapy Development Using Pooled Donor Cord Blood CD34+ Cells as the Starting Material 5:30 pm

View the full event guide for more detailsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.